Maxcyte (DI) (MXCT) RNS Announcements

Add to Alert list
Date Time Source Announcement
23 Nov 2021 07:32 AM
RNS
Purchase of Common Stock
17 Nov 2021 05:36 PM
RNS
Exercise of options and PDMR Dealing
11 Nov 2021 07:00 AM
RNS
MaxCyte Reports Third Quarter Financial Results
03 Nov 2021 01:00 PM
RNS
Appointment of Chairman of the Board
29 Oct 2021 05:01 PM
RNS
Result of AGM
28 Oct 2021 03:00 PM
RNS
License with Nkarta, Inc.
26 Oct 2021 07:00 AM
RNS
Notice of Results
06 Oct 2021 07:00 AM
RNS
Holdings in Company
01 Oct 2021 03:49 PM
RNS
Notice of AGM and Change of Director
01 Oct 2021 12:36 PM
RNS
Total Voting Rights
17 Sep 2021 02:35 PM
RNS
MaxCyte Set to Join Russell 2000® Index
14 Sep 2021 07:00 AM
RNS
Filing of Form 10-Q
14 Sep 2021 07:00 AM
RNS
Half-year Report
06 Sep 2021 05:21 PM
RNS
Issue of Equity and Total Voting Rights
02 Sep 2021 02:26 PM
RNS
Notice of Results
10 Aug 2021 07:00 AM
RNS
Grant of Options
09 Aug 2021 07:00 AM
RNS
License with Sana Biotechnology
05 Aug 2021 04:05 PM
RNS
Amendments to Bylaws
03 Aug 2021 03:51 PM
RNS
Closing of Offering
02 Aug 2021 07:00 AM
RNS
Full Exercise of Over-Allotment Option
30 Jul 2021 04:43 PM
RNS
Second Price Monitoring Extn
30 Jul 2021 04:36 PM
RNS
Price Monitoring Extension
30 Jul 2021 07:00 AM
RNS
Pricing of Offering and Approval to List on Nasdaq
26 Jul 2021 11:14 AM
RNS
Launch of Offering and Application to List
19 Jul 2021 12:30 PM
RNS
Termination of DI facility and transition to CDI
12 Jul 2021 07:00 AM
RNS
S-1 Financial information & Directorate Change
12 Jul 2021 07:00 AM
RNS
Public Filing of Registration Statement with SEC
06 Jul 2021 05:36 PM
RNS
Result of Special Meeting
16 Jun 2021 07:01 AM
RNS
Publication of Annual Report and Accounts
16 Jun 2021 07:00 AM
RNS
Stockholder Circular and Notice of Special Meeting
15 Jun 2021 07:00 AM
RNS
Maxcyte Appoints Two New Non-Executive Directors
02 Jun 2021 09:18 AM
RNS
Total Voting Rights
25 May 2021 07:00 AM
RNS
Signing of Strategic Platform Licence
14 May 2021 07:00 AM
RNS
Proposed Dual-Listing on Nasdaq
13 May 2021 07:00 AM
RNS
Consolidation of Trading Lines
20 Apr 2021 07:00 AM
RNS
Full Year Results
15 Apr 2021 07:00 AM
RNS
Notice of Full Year Results
01 Apr 2021 07:00 AM
RNS
Total Voting Rights
11 Mar 2021 03:01 PM
RNS
Holding(s) in Company
03 Mar 2021 07:00 AM
RNS
Total Voting Rights
23 Feb 2021 07:00 AM
RNS
Participation in Upcoming Investor Conferences
19 Feb 2021 07:00 AM
RNS
Director Dealings and Issue of Equity
17 Feb 2021 05:44 PM
RNS
Grant of Options
15 Feb 2021 04:32 PM
RNS
Holding(s) in Company
12 Feb 2021 01:59 PM
RNS
Holding(s) in Company
08 Feb 2021 02:59 PM
RNS
Holding(s) in Company
05 Feb 2021 09:01 AM
RNS
Price Monitoring Extension
04 Feb 2021 07:00 AM
RNS
Director Dealings and Issue of Equity
04 Feb 2021 07:00 AM
RNS
CORRECTION: MaxCyte Announces £40m Subscription
03 Feb 2021 04:36 PM
RNS
MaxCyte Announces £40 million Subscription
UK 100